Meta-Analysishigh evidence
Efficacy of incretin-based therapies in obesity-related obstructive sleep apnea: a systematic review and meta-analysis of randomized controlled trials.
Sleep medicine reviews·August 1, 2025·PMID 40633481
Why it mattersFor clinicians managing OSA in patients with obesity, this supports GLP-1–based and dual GLP-1/GIP therapy as a potentially useful adjunct that may improve both weight and sleep apnea severity, not just cardiometabolic risk.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled